Protalix BioTherapeutics (PLX) Operating Margin (QoQ) (2010 - 2026)
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Operating Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn |
| 10 | Protalix BioTherapeutics | 217.96 Mn | 177.31 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,917.00 |
| Mar 31, 2026 | 11,372.00 |
| Dec 31, 2025 | -6,300.00 |
| Sep 30, 2025 | 445.00 |
| Jun 30, 2025 | 4,847.00 |
| Mar 31, 2025 | -8,056.00 |
| Dec 31, 2024 | 1,735.00 |
| Sep 30, 2024 | 4,024.00 |
| Jun 30, 2024 | 11,155.00 |
| Mar 31, 2024 | -7,601.00 |
| Dec 31, 2023 | -3,531.00 |
| Sep 30, 2023 | -7,646.00 |
| Jun 30, 2023 | 8,387.00 |
| Mar 31, 2023 | 331.00 |
| Dec 31, 2022 | -692.00 |
| Sep 30, 2022 | 4,108.00 |
| Jun 30, 2022 | -5,148.00 |
| Mar 31, 2022 | 5,512.00 |
| Dec 31, 2021 | -5,111.00 |
| Sep 30, 2021 | 12,698.00 |